Middle East and Africa Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of the Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Middle East and Africa Health Screening Market
Middle East and Africa health screening market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.8% in the forecast period of 2021 to 2028 and is expected to reach USD 9,344.91 million by 2028. The rising number of chronic diseases, geriatric population, and increasing awareness about early detection and treatment of disease are the major drivers that propelled the market's demand in the forecast period.
Health screening is an important method of early detection of a specific disorder. The screening tests are often used in preventative medicine to identify whether an individual shows early signs of a condition's risk factors. The disease, which may be detected by screening includes cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis. A surge in the volume of chronic disease, geriatric population, increasing awareness about early detection and treatment of disease is propelling the growth of the health screening market.
The rising awareness among people about early detection and treatment of disease and increasing health expenditure are increasing the demand for health screening.
Rising demand for health screening because of its efficacy, growing number of service providers, and increasing awareness campaign by private and public players of health screening are propelling the growth of the health screening market in the forecast period by acting as opportunity. However, the high cost of screening test may hamper the market growth in the forecast period.
Middle East and Africa health screening market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Middle East and Africa Health Screening Market Scope and Market Size
Middle East and Africa health screening market is segmented into eight notable segments based on test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of test type, the Middle East and Africa health screening market is segmented into cholesterol tests, diabetes test, cancer screening, general checkup test, STDs, blood pressure test, and others. In 2021, cholesterol test segment is expected to dominate the market because this test is common and the cholesterol level can be easily measured in less infrastructure and medical facilities.
- On the basis of package type, the Middle East and Africa health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check, and others. In 2021, basic health screening segment is expected to dominate the market because of increasing awareness among people and initiatives by global bodies to implement heath camps and an average healthcare facility in these regions
- On the basis of panel type, the Middle East and Africa health screening market is segmented into multi-test panels and single-test panels. In 2021, multi-test panels segment is expected to dominate the market as the disease rate is high in this region especially in Africa which increase the demand for multi-panel test in the forecasted period.
- On the basis of sample type, the Middle East and Africa health screening market is segmented into blood, urine, serum, saliva, and others. In 2021, blood segment is expected to dominate the market because blood test can help identify how well the organs are working such as heart, kidneys, and liver among others.
- On the basis of technology, the Middle East and Africa health screening market is segmented into immunoassays, medical imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in situ hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), and others. In 2021, immunoassays segment is expected to dominate the market because immunoassays are contributing in various applications including blood transfusions, gene therapies, implant operations, screening of infectious diseases and others. Increasing number of surgeries, infectious diseases, and gene therapies are driving the growth of the immunoassays segment.
- On the basis of condition, the Middle East and Africa health screening market is segmented into cardiovascular disease, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-C complications, immunology-related conditions, and others. In 2021, cardiovascular disease segment is expected to dominate the market the disease has a high prevalence and incidence in almost every country around the world and increase obesity and lack of nutrition can also propel the disease incidence
- On the basis of sample collection sites, the Middle East and Africa health screening market is segmented into hospitals, homes, diagnostic laboratories, offices, and others. In 2021, hospitals segment is expected to dominate the market as the funding from global agencies in African Region to develop hospital has increased which is driving the hospital segment in Middle East & Africa Region
- On the basis of distribution channel, the Middle East and Africa health screening market is segmented into direct tenders, retail sales, and others. In 2021, direct tender segment is expected to dominate the market because of increasing presence of companies in these region as African region is highly susceptible to new diseases
Middle East and Africa Health Screening Market Country Level Analysis
Middle East and Africa health screening market is analyzed, and market size information is provided on the test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel.
The countries covered in the Middle East and Africa health screening market are Saudi Arabia, South Africa, Egypt, the Rest of the Middle East and Africa. South Africa in the Middle East and Africa region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 as it is an emerging market which is having huge potential to support health screening market in growing.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Middle East and Africa Health Screening Market are boosting the Market Growth
The Middle East and Africa health screening treatment market also provides you with detailed market analysis for every country's growth in the screening services industry with drugs sales, the impact of advancement, technology, and changes in regulatory scenarios with their support for the health screening treatment market. The data is available for the historic period 2010 to 2019.
Competitive Landscape and Middle East and Africa Health Screening Market Share Analysis
Middle East and Africa health screening market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Middle East and Africa health screening market.
The major companies operating in the Quest Diagnostics Incorporated, GRAIL, Eurofins Scientific, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, Sonic Healthcare Limited, ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, AMEDES Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, H.U Group Holdings, Inc., Lifelabs, ARUP Laboratories, Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, Healius Limited, Telomere Diagnostics, Charles River Laboratories, Ambry Genetics, SpectraCell Laboratories, Inc., Dr. Lal PathLabs, and Laboratory Corporation of America among others.
Many events, agreements, and webinars are also initiated by the companies worldwide, which also accelerates the Middle East and Africa health screening market.
For instances,
- In June 2018, ACM Global Laboratories announced that it has developed Smarter Testing for Oncology to deliver a unique service offering for their clients conducting cancer research. This has increased the company’s customer engagement.
Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player enhance the company market in the Middle East and Africa health screening market, which also benefits the organization to improve their offering health screening services.
SKU-
